Lyophilisation

Product Description

Famar offers lyophilisation services. It can perform aseptic filling and lyophilisation in vials from 2ml to 20ml.
Contact us for more information!

FAMAR ANONYMOUS INDUSTRIAL COMPANY OF PHARMACEUTICALS AND COSMETICS

  • GR
  • 2020
    On CPhI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Contract Service
Manufacturer/Innovator

FAMAR ANONYMOUS INDUSTRIAL COMPANY OF PHARMACEUTICALS AND COSMETICS

  • GR
  • 2020
    On CPhI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Contract Service
Manufacturer/Innovator

More Products from FAMAR ANONYMOUS INDUSTRIAL COMPANY OF PHARMACEUTICALS AND COSMETICS

  • Contract Development Services

    Product Contract Development Services

    Famar R&D is offering a complete set of Contract Development services.

    • Formulation and process development for Rx, Gx, OTC, Cosmetics (Solids, Semi-solids /liquids dosage forms, Sterile liquids & Lyophilized powders) and Medical Devices
    • Analytical methods development and validation 
    • Pilot scale activities 
    • GMP clinical batch manufacturing and labeling (except randomization) 
    • Trouble shooting – risk analysis (manufacturing and QC support)
  • Contract Manufacturing Services

    Product Contract Manufacturing Services

    Famar has a legacy of more than 70 years in Contract Manufacturing. Through a network of 6 production sites in Europe, we provide manufacturing capability for a broad range of dosage forms, for Rx, OTC and Health& Beauty products, in the following forms: 
    • Solid forms
    • Semi-solid and Liquids
    • Sterile and Freeze-dried forms
  • Nasal Sprays

    Product Nasal Sprays

    Famar offers pharmaceutical services which includes nasal sprays. It belongs to liquid forms category. 

    Contact us for more information!
  • Drops

    Product Drops

    Famar offers pharmaceutical services which includes drops. It belongs to liquid forms category. 

    Contact us for more information!
  • Solutions

    Product Solutions

    Famar offers pharmaceutical services which includes solutions. It belongs to liquid forms category. 

    Contact us for more information!
  • Suspensions

    Product Suspensions

    Famar offers pharmaceutical services which includes suspensions. It belongs to liquid forms category. 

    Contact us for more information!
  • Syrups

    Product Syrups

    Famar offers pharmaceutical services which includes syrups. It belongs to liquid forms category. 
    - Syrups
    - Syrups with alcohol 
    Contact us for more information!
  • Lotions

    Product Lotions

    Famar offers pharmaceutical services which includes lotions. It belongs to liquid forms category. 

    Contact us for more information!
  • Suppositories

    Product Suppositories

    Famar offers pharmaceutical services which includes suppositories. It belongs to semi-solid forms category. 

    Contact us for more information!
  • Gels

    Product Gels

    Famar offers pharmaceutical services which includes gels. It belongs to semi-solid forms category. 

    Contact us for more information!
  • Ointments

    Product Ointments

    Famar offers pharmaceutical services which includes ointments. It belongs to semi-solid forms category. 

    Contact us for more information!
  • Creams

    Product Creams

    Famar offers pharmaceutical services which includes creams. It belongs to semi-solid forms category. 

    Contact us for more information!

FAMAR ANONYMOUS INDUSTRIAL COMPANY OF PHARMACEUTICALS AND COSMETICS resources

  • News FAMAR and Medicom Healthcare announce the acquisition by Medicom of the pharmaceutical dossier of BIMATOPROST

    Medicom Healthcare Limited (Medicom) and Famar Health Care Services Madrid (Famar) are pleased to announce the signing of an Asset Purchase Agreement (APA) for the acquisition by Medicom of the pharmaceutical dossier of BIMATOPROST 0.3 mg/mL, 3ml, preservative free eye drop solution, developed by Famar R&D. Medicom and Famar have also entered into a long term Manufacturing and Supply Agreement (MSA) with Famar being the exclusive manufacturer of this product.
  • Video Podcast: The CDMO Response to COVID-19

    The coronavirus pandemic has been incredibly disruptive for all facets of life around the globe, exerting extreme pressure on practically all industry sectors and severely impacting the usual day-to-day interactions they have become accustomed to. The pharmaceutical industry has been thrust into the vanguard of this global crisis, not only in its quest to find effective vaccines or therapeutics to fight the virus but also in its responsibility to continue to manufacture life-changing and essential medicines and ensure they are delivered to patients. Even before the pandemic struck, pharma and biotech have been steadily increasing their outsourcing to contract development and manufacturing organisations (CDMOs) not only to cut costs and have access to manufacturing capacity but also to better deploy their resources and gain access to expertise in other phases of the product lifecycle. This podcast was originally aired as part of the CPhI Festival of Pharma.
  • News FAMAR R&D agreed to deliver clinical trial material of the newly developed eye-drop formulation of Active Biotech

    Famar came in agreement with Active Biotech AB to deliver clinical trial material of the newly developed eye-drop formulation of laquinimod.Famar R&D will provide process development, scale-up, supply of material for pre-clinical local tolerance studies and clinical grade material for use in the clinical studies.
    The clinical safety study is expected by H2 2021.

Recommended products